Clinical trial
Eltrombopag for Moderate Aplastic Anemia
To evaluate the safety and effectiveness of eltrombopag in people with moderate aplastic anemia who need treatment for significantly low blood cell counts.
| Category | Value |
|---|---|
| Study start date | 2011-04-01 |